NONPALPABLE STAGE T1C PROSTATE CANCER
- 1 December 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 2407-2411
- https://doi.org/10.1097/00005392-199812020-00008
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- THE USE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR STAGING CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- Prostate-specific antigen-detected prostate cancer (Stage T1c): An analysis of whole-mount prostatectomy specimensThe Prostate, 1997
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisUrology, 1997
- MOLECULAR FORMS OF SERUM PROSTATE-SPECIFIC ANTIGENUrologic Clinics of North America, 1997
- Impalpable Invisible Stage T1c Prostate Cancer: Characteristics and Clinical Relevance in 100 Radical Prostatectomy Specimens-A Different ViewJournal of Urology, 1997
- The accuracy of transrectal ultrasound prostate volume estimation: Clinical correlationsJournal of Clinical Ultrasound, 1996
- Reassessment of nonplanimetric transrectal ultrasound prostate volume estimatesUrology, 1996
- Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term FollowupJournal of Urology, 1993
- Accuracy of In-Vivo Assessment of Prostatic Volume by MRI and Transrectal UltrasonographyJournal of Computer Assisted Tomography, 1992